Cage Chemicals, IT
Role and Contribution
Cage will lead WP8 on multimodel therapy control. They will work in close cooperation with AAA, University of Turin and UHEI-IKRN in projects in the field of Molecular Imaging. Contributions will also be made to WP2, dissemination and exploitation, as well as WP4, for which Cage will have a major role in the development of new radiopharmaceuticals, evaluation of contrast agents and calculating biodistribution and dosimetry for diagnosis.
Prof. S. Aime is currently Professor of General and Inorganic Chemistry, and Head of the NMR Laboratory of the Department of Chemistry, and the Center for Molecular Imaging at the University of Torino. Professor Aime’s main research is focused on developing diagnostic agents containing lanthanides or hyperpolarised molecules for applications of magnetic resonance imaging with a particular interest in molecular imaging procedures, witnessed by more than 400 peer-reviewed publications and several patents in the field of medical imaging.
Prof. G.B. Giovenzana, PhD: 1995 Degree in Chemistry. 1998 PhD in Chemical Sciences. 1999 Researcher and in 2004 Associate Professor of Organic Chemistry at University of Eastern Piedmont in Novara – Italy. President and Scientific director of CAGE Chemicals Srl.
Dr. Camilla Cavallotti, PhD: 1998 Degree in Industrial Chemistry. 2002 PhD in Chemical Sciences. 2002-2006 Postdoctoral research for Università di Torino and CIRCMSB collaborator in the synthesis of new and improved contrast agents. 2006-now CAGE Chemicals. Experience in organic synthesis and process chemistry with specific expertise in the design and synthesis of contrast agents.